Inzy stock price target
Web1 apr. 2024 · In predicting price targets of as low as $6.00 and as high as $40.00, analysts are in agreement on assigning the stock over the next 12 months average price target … Web12 apr. 2024 · Bunzl plc (LON:BNZL – Get Rating) insider Frank van Zanten sold 21,307 shares of the firm’s stock in a transaction on Tuesday, April 11th.The shares were sold at an average price of GBX 3,066 ...
Inzy stock price target
Did you know?
Web2 aug. 2024 · For Inozyme Pharma stock forecast for 2024, 11 predictions are offered for each month of 2024 with average Inozyme Pharma stock forecast of $2.01, a high … Web6 apr. 2024 · The average price target represents an increase of 262.71% from its latest reported closing price of $5.39. See our leaderboard of companies with the largest price target upside. ... This is a decrease of 11 owner(s) or 13.92% in the last quarter. Average portfolio weight of all funds dedicated to INZY is 0.04%, ...
Web8 apr. 2024 · According to the issued ratings of 4 analysts in the last year, the consensus rating for Inozyme Pharma stock is Buy based on the current 4 buy ratings for INZY. The average twelve-month price prediction for Inozyme Pharma is $16.00 with a high … WebBased on analysts offering 12 month price targets for INZY in the last 3 months. The average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00 .
Web5 uur geleden · BOSTON, April 14, 2024 -- Inozyme Pharma, Inc. , a clinical-stage rare disease biopharmaceutical company developing novel therapeutics for the treatment of pathologic mineralization and... April 14, 2024 Web22 dec. 2024 · InvestorsObserver is giving Inozyme Pharma Inc (INZY) an Analyst Rating Rank of 79, meaning INZY is ranked higher by analysts than 79% of stocks. ... (INZY) Stock's Target Price? Tuesday, December 22, 2024 02:41 PM InvestorsObserver Analysts. Mentioned in this article.
WebThe latest price target for . Inozyme Pharma (NASDAQ: INZY) was reported by Jefferies on Thursday, March 23, 2024.The analyst firm set a price target for 6.00 expecting INZY to …
Web14 apr. 2024 · The average 12-month price objective among brokerages that have covered the stock in the last year is $83.00. A number of research analysts have recently commented on the stock. Wells Fargo & Company reduced their target price on shares of UMB Financial from $95.00 to $85.00 and set an “equal weight” rating on the stock in a … diamond painting shop magdeburgWebInozyme Pharma (INZY) Stock Price & Analysis. Follow. 160 Followers. Portfolio. INZY Stock Chart & Stats. Advanced Chart > 1d 5d 3m 6m YTD 1y 3y 5y. Day’s Range $0 - … cirstenw funeralWeb8 apr. 2024 · INZY has a significant gap to fill from current levels since trading over $30 shortly after its IPO in 2024. 2 weeks ago, Jefferies upgraded its outlook for Inozyme from Hold to Buy. As of March 24, 2024, the average one-year price target for Inozyme Pharma is $19.46 for what its worth, they were also saying that when INZY was $1. diamond-painting-shopWeb6 apr. 2024 · INZY Stock Overview. Inozyme Pharma, Inc., a clinical-stage biopharmaceutical company, ... Price target decreased by 13% to US$19.17 Mar 29. … diamond painting shop österreichWeb8 okt. 2024 · 🚀 Inozyme Pharma stock price forecast: $40; Market Cap: 104.37M, Enterprise value: N/A, P/E: -0.91, PEG ratio: -0.01, EPS: -2.74, Revenue: N/A, EBITDA: -65.13M ... cirsten w in hidingWebGet the latest Inozyme Pharma Inc (INZY) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment … diamond painting shitzu dogWeb13 apr. 2024 · Finance. Industry. Market cirsten w jeffery pritchett beforeitsnews